Hikma Pharmaceuticals PLC (LSE:HIK) - Overview

Stock Report

Hikma Pharmaceuticals PLC HIK

Last Price
GBX1,724.00

Day Change
23.00|1.35%

As of 09/12/2016
17:01:50 GMT | GBX
Minimum 15 Minutes Delay.

Last Close1,701.00p
Day Range1,694.00 - 1,738.00
Mkt Cap4.08Bil
52-Wk Range1,575.00 - 2,703.00
Yield %0.97
ISINGB00B0LCW083
Volume642,477
P/E18.87
P/S3.53
P/CF15.88

Share Price

Total Returns 08/12/2016

 Chg (%)  
More ...
Hikma Pharmaceuticals PLC2.29 
FTSE 100 TR GBP1.73
 
Financials
201320142015
More ...
Income Statement
Turnover876.80906.03971.99
Operating Profit226.11244.61257.17
Net Profit138.75171.59171.45
Reported EPS68.8084.5884.64
Balance Sheet
Current Assets543.97650.84917.99
Non Current Assets625.83795.39834.97
Total Assets1,169.801,446.231,752.95
Current Liabilities355.37540.33399.60
Total Liabilities542.76664.97840.37
Total Equity627.05781.26912.59
Cash Flow
Operating Cash Flow270.43306.67281.47
Net Change in Cash-4.5068.76189.67
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016217.8787.20-4.5519.51-4.2820.131.18
2017388.51110.4926.7115.400.5828.541.68

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
06/12/2016PurchaseMr. Mazen Darwazah1,682.00100,0001,682,000.00
06/12/2016PurchaseMohammed Ali Al-Husry1,682.00100,0001,682,000.00
06/12/2016PurchaseMr. Said Darwazah1,682.00100,0001,682,000.00
05/12/2016PurchaseMr. Mazen Darwazah1,674.0050,000837,000.00

Company Profile

Hikma Pharmaceuticals PLC is engaged in the development, manufacture and marketing of broad range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms.
 

Sector

Drug Manufacturers - Specialty & Generic

Market Position

103 of 1863 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE All Share

Outlook

(10/11/2016) "...we remain highly confident in the future prospects of the business"

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)15.6013.3915.97
Div Yld (E)1.654.244.18
PEG (E)0.630.220.27
ROCE25.30204.18-30.67
Op Mrgn26.11-17.37-33.06
EPS Grwth24.659.7722.66
Dividends
PreviousLatest
More ...
Record Date08/04/1602/09/16
Ex-Div07/04/1601/09/16
Paid19/05/1630/09/16
Amnt14.478.45

Broker Sentiment

Strong Buy0
Buy3
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
Chairman & Chief Executive OfficerMr. Said Darwazah
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.